[8], were able to obtain postmortem brain tissue from patients who had been treated with BrdU (5-bromo-3-deoxyuridine, a thymidine analogue that labels DNA) as a diagnostic biomarker
10.3390/ijms21113743 Int J Mol Sci
This retrospective study aims to compare surgical outcomes before and following the implementation of the ASA guidelines to determine the role of GLP-1RAs in these outcomes
In the first three months of our collaboration, we achieved a 14% reduction in overall specialty drug spend, an average of $917 in savings per prescription
Ophthalmic Complications Associated With the Antidiabetic Drugs Semaglutide and Tirzepatide Katz BJ et al
04, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company, today shared new real-world findings from tens of thousands of members, showing a clear relationship: members who engage more with Noom's leading GLP-1 Companion app tend to lose more weight and stay on a medication program longer